[1]
“Low Prevalence of High-dose Methotrexate Nephropathy in Patients With Malignancy”, IJKD, vol. 6, no. 2, pp. 105–109, Mar. 2012, Accessed: Nov. 23, 2024. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/643